A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (PATHFNDR-2)
Clinical trial NCT05192382 · TERMINATED
Trial details
- NCT number
- NCT05192382
- Sponsor
- Crinetics Pharmaceuticals Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-17
- Primary completion
- 2024-01-20
- Enrollment
- 111
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.